• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不稳定的调节性 T 细胞,富含幼稚细胞和 Nrp1 细胞,在命运挑战后被清除。

Unstable regulatory T cells, enriched for naïve and Nrp1 cells, are purged after fate challenge.

机构信息

KU Leuven-University of Leuven, Department of Microbiology, Immunology and Transplantation, Leuven 3000, Belgium.

VIB Center for Brain and Disease Research, Leuven 3000, Belgium.

出版信息

Sci Immunol. 2021 Jul 23;6(61). doi: 10.1126/sciimmunol.abe4723.

DOI:10.1126/sciimmunol.abe4723
PMID:34301799
Abstract

Regulatory T cells (T) are indispensable for the control of immune homeostasis and have clinical potential as a cell therapy for treating autoimmunity. T can lose expression of the lineage-defining Foxp3 transcription factor and acquire effector T cell (T) characteristics, a process referred to as T plasticity. The extent and reversibility of such plasticity during immune responses remain unknown. Here, using a murine genetic fate-mapping system, we show that T stability is maintained even during exposure to a complex microbial/antigenic environment. Furthermore, we demonstrate that the observed plasticity of T after adoptive transfer into a lymphopenic environment is a property limited to only a subset of the T population, with the nonconverting majority of T being resistant to plasticity upon secondary stability challenge. The unstable T fraction is a complex mixture of phenotypically distinct T, enriched for naïve and neuropilin-1-negative T, and includes peripherally induced T and recent thymic emigrant T These results suggest that a "purging" process can be used to purify stable T that are capable of robust fate retention, with potential implications for improving cell transfer therapy.

摘要

调节性 T 细胞(T)对于控制免疫稳态是不可或缺的,并且具有作为治疗自身免疫病的细胞治疗的临床潜力。T 细胞可以失去谱系定义性 Foxp3 转录因子的表达,并获得效应 T 细胞(T)特征,这一过程称为 T 细胞可塑性。在免疫反应期间,这种可塑性的程度和可逆性仍然未知。在这里,我们使用一种小鼠遗传谱系追踪系统表明,即使在暴露于复杂的微生物/抗原环境中,T 细胞的稳定性也得以维持。此外,我们证明,在淋巴减少环境中进行过继转移后观察到的 T 细胞的可塑性是仅局限于 T 细胞群体的一个子集的特性,大多数未转化的 T 细胞在二次稳定性挑战时对可塑性具有抗性。不稳定的 T 细胞亚群是表型上明显不同的 T 细胞的复杂混合物,富含幼稚和神经纤毛蛋白-1 阴性 T 细胞,包括外周诱导的 T 细胞和近期胸腺迁出的 T 细胞。这些结果表明,可以使用“清除”过程来纯化具有强大命运保留能力的稳定 T 细胞,这可能对改善细胞转移治疗具有重要意义。

相似文献

1
Unstable regulatory T cells, enriched for naïve and Nrp1 cells, are purged after fate challenge.不稳定的调节性 T 细胞,富含幼稚细胞和 Nrp1 细胞,在命运挑战后被清除。
Sci Immunol. 2021 Jul 23;6(61). doi: 10.1126/sciimmunol.abe4723.
2
Daurinol Attenuates Autoimmune Arthritis via Stabilization of Nrp1-PTEN-Foxp3 Signaling in Regulatory T Cells.道立诺通过稳定调节性 T 细胞中 Nrp1-PTEN-Foxp3 信号来减轻自身免疫性关节炎。
Front Immunol. 2019 Jul 17;10:1526. doi: 10.3389/fimmu.2019.01526. eCollection 2019.
3
A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.一种神经纤毛蛋白-1 拮抗剂通过抑制肿瘤内调节性 T 细胞的抑制功能发挥抗肿瘤免疫作用。
Cancer Immunol Res. 2020 Jan;8(1):46-56. doi: 10.1158/2326-6066.CIR-19-0143. Epub 2019 Sep 25.
4
Functional plasticity of antigen-specific regulatory T cells in context of tumor.肿瘤微环境中抗原特异性调节性 T 细胞的功能可塑性。
J Immunol. 2011 Apr 15;186(8):4557-64. doi: 10.4049/jimmunol.1003797. Epub 2011 Mar 9.
5
Regulatory T Cell Insufficiency in Autoimmune Diabetes Is Driven by Selective Loss of Neuropilin-1 on Intraislet Regulatory T Cells.胰岛内调节性 T 细胞上神经纤毛蛋白-1 的选择性缺失导致自身免疫性糖尿病中调节性 T 细胞功能不全。
J Immunol. 2024 Sep 15;213(6):779-794. doi: 10.4049/jimmunol.2300216.
6
Once a Treg, always a Treg?一旦成为调节性T细胞,就永远是调节性T细胞?
Immunol Rev. 2014 May;259(1):173-91. doi: 10.1111/imr.12173.
7
Cancer Exacerbates Ischemic Brain Injury Via Nrp1 (Neuropilin 1)-Mediated Accumulation of Regulatory T Cells Within the Tumor.癌症通过 Nrp1(神经纤毛蛋白 1)介导的肿瘤内调节性 T 细胞的积累加剧缺血性脑损伤。
Stroke. 2018 Nov;49(11):2733-2742. doi: 10.1161/STROKEAHA.118.021948.
8
CARD11 is dispensable for homeostatic responses and suppressive activity of peripherally induced FOXP3 regulatory T cells.CARD11 对于外周诱导的 FOXP3 调节性 T 细胞的稳态反应和抑制活性是可有可无的。
Immunol Cell Biol. 2019 Sep;97(8):740-752. doi: 10.1111/imcb.12268. Epub 2019 Jun 26.
9
Egress of mature murine regulatory T cells from the thymus requires RelA.成熟的小鼠调节性T细胞从胸腺中流出需要RelA。
J Immunol. 2015 Apr 1;194(7):3020-8. doi: 10.4049/jimmunol.1302756. Epub 2015 Feb 27.
10
Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.激动剂抗 GITR 单克隆抗体通过改变调节性 T 细胞的稳定性和肿瘤内蓄积,诱导小鼠黑色素瘤肿瘤免疫。
PLoS One. 2010 May 3;5(5):e10436. doi: 10.1371/journal.pone.0010436.

引用本文的文献

1
Iron and energy metabolic interactions in Treg-mediated immune regulation.调节性T细胞介导的免疫调节中的铁与能量代谢相互作用
Front Immunol. 2025 Mar 19;16:1554028. doi: 10.3389/fimmu.2025.1554028. eCollection 2025.
2
CD4FOXP3Exon2 regulatory T cell frequency predicts breast cancer prognosis and survival.CD4FOXP3外显子2调节性T细胞频率可预测乳腺癌的预后和生存情况。
Sci Adv. 2025 Jan 17;11(3):eadr7934. doi: 10.1126/sciadv.adr7934. Epub 2025 Jan 15.
3
The 'T paradox' in inflammatory arthritis.炎症性关节炎中的“T悖论”。
Nat Rev Rheumatol. 2025 Jan;21(1):9-21. doi: 10.1038/s41584-024-01190-w. Epub 2024 Dec 9.
4
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review.调节性 T 细胞在肿瘤微环境中的潜在抗肿瘤作用:综述。
J Transl Med. 2024 Mar 20;22(1):293. doi: 10.1186/s12967-024-05104-y.
5
Regulatory T Cells for Control of Autoimmunity.调节性 T 细胞在自身免疫控制中的作用
Adv Exp Med Biol. 2024;1444:67-82. doi: 10.1007/978-981-99-9781-7_5.
6
Selective targeting or reprogramming of intra-tumoral Tregs.肿瘤内调节性T细胞的选择性靶向或重编程。
Med Oncol. 2024 Feb 11;41(3):71. doi: 10.1007/s12032-024-02300-0.
7
Selective ablation of thymic and peripheral Foxp3 regulatory T cell development.选择性消融胸腺和外周 Foxp3 调节性 T 细胞发育。
Front Immunol. 2023 Dec 18;14:1298938. doi: 10.3389/fimmu.2023.1298938. eCollection 2023.
8
"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity".“针对自身免疫中的调节性 T 细胞的 IL-2 免疫疗法”。
Genes Immun. 2023 Oct;24(5):248-262. doi: 10.1038/s41435-023-00221-y. Epub 2023 Sep 23.
9
Diabetic complications and prospective immunotherapy.糖尿病并发症与前瞻性免疫疗法。
Front Immunol. 2023 Jul 7;14:1219598. doi: 10.3389/fimmu.2023.1219598. eCollection 2023.
10
Autoimmune diseases and gut microbiota: a bibliometric and visual analysis from 2004 to 2022.自身免疫性疾病与肠道微生物群:2004 年至 2022 年的文献计量学和可视化分析。
Clin Exp Med. 2023 Oct;23(6):2813-2827. doi: 10.1007/s10238-023-01028-x. Epub 2023 Mar 1.